Clinical Trial Update: Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating tacrolimus ointment 0.1% as maintenance therapy for non-segmental vitiligo versus control has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Tacrolimus Ointment (0.1%) (tacrolimus)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Pigmentation Disorders, Vitiligo | Phase 2, Phase 3 | Status: TERMINATED